Sesame’s platform enables uninsured and underinsured patients to research and shop for physicians by price and book in-person or telehealth appointments for a variety of specialties, paying by cash or via a monthly fee. Visits average less than $40 apiece and start as low as $25, the company said.
The startup said it will use the funding to transition its monthly subscription model from beta to general availability.
“Sesame provides greater access to healthcare for a meaningful percentage of the population, and we’re inspired by the company’s mission to drive better patient outcomes for underserved communities,” said Cathy Friedman, executive venture partner at GV, in a June 14 Sesame news release. “Sesame presents a compelling opportunity to develop a dynamic marketplace at a scale unlike any in the current U.S. healthcare ecosystem.”
The company was founded in 2018 by David Goldhill, who authored The Real Costs of American Health Care and a 2009 Atlantic article, “How American Health Care Killed my Father.” Mr. Goldhill is chair of healthcare watchdog the Leapfrog Group.
The investment brings Sesame’s total funding to $75 million, according to Crunchbase. Other investors include Virgin Group and General Catalyst.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
